Panel Discussion: Balancing Speed, Cost, and Compliance in Pharma & Biotech Expansions

When pharma and biotech organizations expand manufacturing capacity or strengthen supply chains, project leaders face a three-way pressure test: deliver fast, stay within budget, and meet stringent compliance requirements. In this panel, senior project and portfolio managers will share real-world lessons from major CapEx projects and facility expansions — what worked, what didn’t, and what they’d do differently.

• Managing timelines under pressure: How to accelerate construction, validation, and tech transfer without creating costly rework.

• CapEx risk management: Practical approaches to avoid cost overruns, scope creep, and contractor misalignment.

• Compliance integration: Embedding regulatory and quality considerations early so they don’t derail timelines.

• Supply chain resilience: Lessons from disruptions — how to future-proof expansions against shortages, geopolitical risks, and global shocks.

• Internal vs. external execution: Balancing in-house expertise with EPC firms, CMOs, and contractors.

• Digital enablement: Where data, AI, and project management platforms are making a tangible difference in complex CapEx delivery.